Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_37010 | 127 | 2.64 | Mlig455_012355 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.232/0.00085 |
Mlig455_012355 {REF} {Length: 7737} {Pfam: HGWP repeat [PF03578.17, score=19.0]} {RNA1509_28298} {RNA1310_3268} {RNA815_628} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.554 | 2.145 | 0.94876 | 1.00000 | |
RegionR2 | 4.232 | 2.145 | 0.00001 | 0.00085 | |
RegionR3 | 0.702 | 2.145 | 0.44074 | 0.95679 | |
RegionR4 | -1.884 | 2.145 | 0.99818 | 1.00000 | |
RegionR5 | -1.021 | 2.145 | 0.98442 | 1.00000 | |
RegionR6 | 0.511 | 2.145 | 0.56707 | 1.00000 | |
RegionR7 | 1.864 | 2.145 | 0.12805 | 0.67383 | |
RegionR8 | -3.85 | 2.145 | 0.28580 | 0.91299 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -3.225 | 2.145 | 0.62727 | 1.00000 | |
RegenerationR2 | 0.522 | 2.145 | 0.30645 | 0.74690 | |
RegenerationR3 | 1.818 | 2.145 | 0.02660 | 0.29381 | |
RegenerationR4 | 1.63 | 2.145 | 0.06585 | 0.40934 | |
RegenerationR5 | 1.314 | 2.145 | 0.12405 | 0.52655 | |
RegenerationR6 | 1.015 | 2.145 | 0.27322 | 0.62294 | |
RegenerationBL | 2.368 | 2.145 | 0.12085 | 0.41246 | |
RegenerationTP | 3.489 | 2.145 | 0.04666 | 0.35709 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_37010 | 127 | 2.64 | Mlig455_012355 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.232/0.00085 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_012355 {REF} {Length: 7737} {Pfam: HGWP repeat [PF03578.17, score=19.0]} {RNA1509_28298} {RNA1310_3268} {RNA815_628} | |
2. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 4.35 | 0.880 | - | 0.738 | 0.876 | 0.951 | 0.905 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
3. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
4.325 | 0.764 | - | 0.869 | 0.829 | 0.881 | 0.982 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
4. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
4.322 | 0.704 | - | 0.906 | 0.861 | 0.961 | 0.890 | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
5. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
4.319 | 0.814 | - | 0.777 | 0.877 | 0.962 | 0.889 | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
6. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 4.285 | 0.721 | - | 0.967 | 0.856 | 0.846 | 0.895 | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
7. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
4.28 | 0.750 | - | 0.856 | 0.949 | 0.959 | 0.766 | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
8. | MligTC455_33704 | 135 | 2.81 | Mlig455_002733 | Neo: - Age: Up-Down-Down |
COL5A2 | 4.265 | 0.822 | 0.751 | 0.902 | 0.957 | - | 0.833 | Mlig455_002733 {REF} {Length: 6615} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=136.4]; Myotubularin protein [PF12335.10, score=23.9]} {Human: ENSG00000204262, COL5A2, collagen type V alpha 2 chain, [Score=113, Expect=6e-25]; ENSG00000049089, COL9A2, collagen type IX alpha 2 chain, [Score=111, Expect=1e-24]} {Mouse: ENSMUSG00000026147, Col9a1, collagen, type IX, alpha 1, [Score=124, Expect=2e-28]; ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=122, Expect=1e-27]; ENSMUSG00000041984, Rptn, repetin, [Score=121, Expect=1e-27]; ENSMUSG00000045672, Col27a1, collagen, type XXVII, alpha 1, [Score=120, Expect=3e-27]} {Dmel: FBgn0016075, vkg, viking, [Score=106, Expect=5e-23]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=84.0, Expect=2e-16]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=140, Expect=9e-34]} {RNA1310_28728} {RNA815_22052} |
9. | MligTC455_36842 | 340 | 7.08 | Mlig455_056552 | Neo: - Age: - Region-enriched R2: 2.409/0.00668 |
SYT11 | 4.256 | 0.742 | - | 0.958 | 0.842 | 0.830 | 0.884 | Mlig455_056552 {REF} {Length: 3533} {Pfam: C2 domain [PF00168.32, score=153.6]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=310, Expect=7e-102]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=309, Expect=8e-102]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=355, Expect=3e-119]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=237, Expect=1e-74]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [Score=372, Expect=4e-127]} {RNA1509_16916, RNA1509_47189} {RNA1310_9964.1, RNA1509_16916, RNA1509_47189} {RNA1509_16916, RNA1509_47189, RNA815_17687} |
10. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 4.123 | - | 0.717 | 0.805 | 0.843 | 0.986 | 0.772 | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
11. | MligTC455_39012 | 61 | 1.27 | Mlig455_030044 | Neo: - Age: Up-Down-Up |
PLCB3 | 4.042 | 0.729 | - | 0.963 | 0.834 | 0.794 | 0.722 | Mlig455_030044 {REF} {Length: 5860} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=196.5]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=125.0]; PH domain [PF17787.3, score=121.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=32.2]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=823, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=823, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=811, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=666, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=681, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555} {RNA815_2033} |
12. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
3.635 | 0.845 | - | 0.974 | 0.943 | - | 0.873 | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
13. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
3.628 | - | - | 0.956 | 0.886 | 0.851 | 0.935 | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
14. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 3.625 | - | - | 0.956 | 0.867 | 0.903 | 0.899 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
15. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
3.622 | - | - | 0.955 | 0.883 | 0.851 | 0.933 | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
16. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
3.619 | - | - | 0.900 | 0.857 | 0.973 | 0.889 | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
17. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
3.61 | - | - | 0.891 | 0.877 | 0.955 | 0.887 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
18. | MligTC455_12545 | 37 | 0.76 | Mlig455_069121 | Neo: - Age: - |
3.603 | - | - | 0.761 | 0.945 | 0.935 | 0.962 | Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125} | |
19. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 3.573 | - | - | 0.841 | 0.886 | 0.888 | 0.958 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
20. | MligTC455_40874 | 65 | 1.34 | Mlig455_051048 | Neo: - Age: - |
ASIC5 | 3.568 | - | 0.874 | - | 0.808 | 0.959 | 0.927 | Mlig455_051048 {REF} {Length: 2313} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=194.4]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=54.3, Expect=4e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=64.7, Expect=1e-10]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [RH, Score=491, Expect=1e-167]} {RNA1509_56048} {RNA1310_34335} {RNA815_62672} |
21. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 3.568 | - | - | 0.927 | 0.843 | 0.840 | 0.958 | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
22. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
3.546 | - | - | 0.830 | 0.870 | 0.957 | 0.889 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
23. | MligTC455_33703 | 69 | 1.44 | Mlig455_002442 | Neo: - Age: - |
3.543 | - | - | 0.965 | 0.831 | 0.834 | 0.913 | Mlig455_002442 {REF} {Length: 1320} {NoTransDecoderORF} {RNA1310_44761} {RNA815_22052} | |
24. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
3.54 | - | - | 0.827 | 0.874 | 0.875 | 0.964 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
25. | MligTC455_48490 | 40 | 0.84 | Mlig455_020090 | Neo: - Age: - |
3.533 | - | - | 0.886 | 0.861 | 0.954 | 0.832 | Mlig455_020090 {REF} {Length: 2619} {RNA1310_71062} {RNA815_63441} | |
26. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
3.526 | - | - | 0.875 | 0.800 | 0.966 | 0.885 | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
27. | MligTC455_36285 | 232 | 4.84 | Mlig455_049585 | Neo: - Age: - Region-enriched R2: 2.764/0.02680 |
SGSM1 | 3.523 | - | - | 0.908 | 0.805 | 0.979 | 0.831 | Mlig455_049585 {REF} {Length: 3668} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=117.8]; Rab-binding domain (RBD) [PF12068.10, score=107.7]; RUN domain [PF02759.21, score=79.1]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [RH, Score=428, Expect=4e-132]} {Mouse: ENSMUSG00000038351, Sgsm2, small G protein signaling modulator 2, [RH, Score=637, Expect=0.0]} {Dmel: FBgn0031116, CG1695, [RH, Score=432, Expect=5e-133]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [RH, Score=421, Expect=2e-131]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [RH, Score=609, Expect=0.0]} {RNA1509_48678} {RNA1310_9224, RNA1509_48678} {RNA1509_48678, RNA815_14977} |
28. | MligTC455_42784 | 842 | 17.55 | Mlig455_004621, Mlig455_004630, Mlig455_004657 | Neo: - Age: - Region-enriched R2: 2.895/0.00752 |
3.504 | - | - | 0.798 | 0.888 | 0.866 | 0.952 | Mlig455_004621 {REF} {Length: 1246} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} Mlig455_004630 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.2} {RNA815_16689.1} Mlig455_004657 {REF} {Length: 1250} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} |
|
29. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.5 | - | - | 0.887 | 0.804 | 0.855 | 0.954 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
30. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 3.448 | - | - | 0.789 | 0.874 | 0.832 | 0.953 | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
31. | MligTC455_47949 | 48 | 1 | Mlig455_026482, Mlig455_026492 | Neo: - Age: - |
CHRNA3 | 3.432 | 0.707 | - | 0.962 | 0.856 | 0.907 | - | Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} |
32. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 3.422 | - | - | 0.771 | 0.874 | 0.825 | 0.952 | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
33. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 3.418 | - | - | 0.960 | 0.702 | 0.901 | 0.855 | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
34. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 3.41 | - | - | 0.806 | 0.799 | 0.852 | 0.953 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
35. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
3.392 | 0.788 | - | - | 0.880 | 0.760 | 0.964 | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
36. | MligTC455_33287 | 444 | 9.24 | Mlig455_061811 | Neo: - Age: - Region-enriched R2: 4.031/0.00004 |
3.387 | - | - | 0.830 | 0.784 | 0.955 | 0.818 | Mlig455_061811 {REF} {Length: 782} {RNA1509_48963} {RNA1310_53012} {RNA815_23468} | |
37. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 3.37 | - | - | 0.760 | 0.768 | 0.877 | 0.965 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
38. | MligTC455_42780 | 194 | 4.05 | Mlig455_053699 | Neo: - Age: - |
TIA1 | 3.361 | - | - | 0.961 | 0.749 | 0.756 | 0.895 | Mlig455_053699 {REF} {Length: 2917} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=137.6]; RNA binding motif [PF08777.13, score=27.7]; RNA recognition motif [PF16367.7, score=27.3]; Cytosolic domain of 10TM putative phosphate transporter [PF14703.8, score=22.0]; Nup53/35/40-type RNA recognition motif [PF05172.15, score=19.3]; Nup53/35/40-type RNA recognition motif [PF14605.8, score=19.0]} {Human: ENSG00000116001, TIA1, TIA1 cytotoxic granule associated RNA binding protein, [RH, Score=237, Expect=3e-74]} {Mouse: ENSMUSG00000071337, Tia1, cytotoxic granule-associated RNA binding protein 1, [RH, Score=234, Expect=2e-73]; ENSMUSG00000030846, Tial1, Tia1 cytotoxic granule-associated RNA binding protein-like 1, [RH, Score=225, Expect=2e-70]} {Dmel: FBgn0085391, trv, trivet, [RH, Score=240, Expect=2e-74]} {Celegans: WBGene00015943, tiar-1, TIA-1/TIAL RNA binding protein homolog, [RH, Score=231, Expect=6e-72]} {Smed: dd_Smed_v6_10924_0_1, dd_Smed_v6_10924_0_1, [RH, Score=360, Expect=8e-123]} {RNA1509_20262} {RNA1310_6771, RNA1509_20262} {RNA1509_20262, RNA815_11494} |
39. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 3.334 | 0.831 | - | 0.816 | 0.734 | - | 0.953 | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
40. | MligTC455_09455 | 51 | 1.06 | Mlig455_029990 | Neo: - Age: - Region-enriched R2: 4.710/0.00601 |
3.296 | 0.741 | 0.709 | 0.974 | - | - | 0.872 | Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143} | |
41. | MligTC455_37847 | 70 | 1.46 | Mlig455_049316 | Neo: - Age: - |
SLC22A15 | 3.241 | 0.813 | - | 0.956 | 0.769 | - | 0.703 | Mlig455_049316 {REF} {Length: 2542} {Pfam: Sugar (and other) transporter [PF00083.26, score=46.4]} {Human: ENSG00000163393, SLC22A15, solute carrier family 22 member 15, [Score=114, Expect=9e-28]; ENSG00000112499, SLC22A2, solute carrier family 22 member 2, [Score=113, Expect=2e-27]; ENSG00000146477, SLC22A3, solute carrier family 22 member 3, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000023829, Slc22a1, solute carrier family 22 (organic cation transporter), member 1, [Score=118, Expect=3e-29]; ENSMUSG00000033147, Slc22a15, solute carrier family 22 (organic anion/cation transporter), member 15, [Score=115, Expect=3e-28]; ENSMUSG00000063652, Slc22a21, solute carrier family 22 (organic cation transporter), member 21, [Score=114, Expect=1e-27]} {Dmel: FBgn0019952, Orct, Organic cation transporter, [Score=132, Expect=3e-34]} {Celegans: WBGene00003842, oct-1, Organic cation transporter 1, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_10826_0_2, dd_Smed_v6_10826_0_2, [Score=114, Expect=3e-28]} {RNA1509_46580} {RNA1310_33722} {RNA815_7677} |
42. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 3.203 | - | 0.766 | 0.718 | - | 0.967 | 0.752 | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
43. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 3.191 | - | - | 0.710 | 0.769 | 0.974 | 0.738 | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
44. | MligTC455_20915 | 255 | 5.32 | Mlig455_005524, Mlig455_036226 | Neo: - Age: Up-Down-Down Region-enriched R7: 2.854/0.02272 |
KCNH4, KCNH8 | 3.132 | - | - | 0.958 | 0.711 | 0.707 | 0.756 | Mlig455_005524 {REF} {Length: 4123} {Pfam: Ion transport protein [PF00520.33, score=96.1]; PAS domain [PF13426.9, score=61.1]; Ion channel [PF07885.18, score=43.6]; Cyclic nucleotide-binding domain [PF00027.31, score=33.1]} {Human: ENSG00000089558, KCNH4, potassium voltage-gated channel subfamily H member 4, [RH, Score=669, Expect=0.0]} {Mouse: ENSMUSG00000035580, Kcnh8, potassium voltage-gated channel, subfamily H (eag-related), member 8, [RH, Score=636, Expect=0.0]} {Dmel: FBgn0011589, Elk, Eag-like K[+] channel, [RH, Score=739, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=418, Expect=1e-130]} {Smed: dd_Smed_v6_10983_0_1, dd_Smed_v6_10983_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_21105} {RNA1310_3536.2} {RNA815_16536} Mlig455_036226 {REF} {Length: 4010} {Pfam: Ion transport protein [PF00520.33, score=96.2]; PAS domain [PF13426.9, score=61.1]; Ion channel [PF07885.18, score=43.6]; Cyclic nucleotide-binding domain [PF00027.31, score=33.1]} {Human: ENSG00000183960, KCNH8, potassium voltage-gated channel subfamily H member 8, [RH, Score=704, Expect=0.0]} {Mouse: ENSMUSG00000035355, Kcnh4, potassium voltage-gated channel, subfamily H (eag-related), member 4, [RH, Score=659, Expect=0.0]; ENSMUSG00000035580, Kcnh8, potassium voltage-gated channel, subfamily H (eag-related), member 8, [RH, Score=634, Expect=0.0]} {Dmel: FBgn0011589, Elk, Eag-like K[+] channel, [RH, Score=739, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=419, Expect=1e-130]} {Smed: dd_Smed_v6_10983_0_1, dd_Smed_v6_10983_0_1, [RH, Score=836, Expect=0.0]} {RNA1509_21105} {RNA1310_3536.2} {RNA815_16536} |
45. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 2.835 | - | - | 0.970 | 0.936 | - | 0.929 | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
46. | MligTC455_52788 | 41 | 0.86 | Mlig455_016296 | Neo: - Age: - |
FCN1 | 2.771 | - | - | - | 0.872 | 0.949 | 0.950 | Mlig455_016296 {REF} {Length: 1559} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=167.4]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=141, Expect=2e-39]; ENSG00000160339, FCN2, ficolin 2, [Score=139, Expect=3e-39]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=134, Expect=2e-35]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [RH, Score=135, Expect=4e-37]} {Dmel: FBgn0003326, sca, scabrous, [RH, Score=128, Expect=4e-33]} {Celegans: WBGene00020516, T15B7.1, [Score=59.3, Expect=6e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=110, Expect=4e-27]} {RNA1310_57278} {RNA815_33549} |
47. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 2.765 | - | - | 0.944 | 0.857 | - | 0.964 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
48. | MligTC455_15759 | 90 | 1.87 | Mlig455_011069 | Neo: - Age: - |
PCDH9 | 2.756 | - | - | - | 0.901 | 0.952 | 0.903 | Mlig455_011069 {REF} {Length: 3981} {Pfam: Cadherin domain [PF00028.19, score=243.4]; Cadherin-like [PF16184.7, score=38.3]; Cadherin-like [PF08266.14, score=33.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=271, Expect=2e-74]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=266, Expect=4e-73]} {Dmel: FBgn0001075, ft, fat, [Score=216, Expect=2e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=163, Expect=3e-40]} {Smed: dd_Smed_v6_16610_0_1, dd_Smed_v6_16610_0_1, [RH, Score=271, Expect=6e-76]} {RNA1310_20741} {RNA815_3048.1} |
49. | MligTC455_33552 | 905 | 18.86 | Mlig455_014406, Mlig455_070160 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.705/0.03873 |
KCNH1 | 2.75 | - | - | 0.950 | - | 0.866 | 0.934 | Mlig455_014406 {REF} {Length: 5774} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=54.1]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=256, Expect=1e-74]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=267, Expect=4e-79]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=256, Expect=3e-75]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=283, Expect=5e-84]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=240, Expect=1e-69]} {Smed: dd_Smed_v6_23063_0_1, dd_Smed_v6_23063_0_1, [Score=283, Expect=7e-86]} {RNA1509_16580} {RNA1310_9615} {RNA815_20522} Mlig455_070160 {REF} {Length: 3641} {Pfam: Ion transport protein [PF00520.33, score=111.5]; Cyclic nucleotide-binding domain [PF00027.31, score=53.3]; Ion channel [PF07885.18, score=40.6]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=771, Expect=0.0]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=794, Expect=0.0]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=770, Expect=0.0]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=838, Expect=0.0]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=688, Expect=0.0]} {Smed: dd_Smed_v6_18793_0_1, dd_Smed_v6_18793_0_1, [Score=895, Expect=0.0]} {RNA1509_16580} {RNA1310_6070} {RNA815_18231} |
50. | MligTC455_51288 | 32 | 0.66 | Mlig455_033307 | Neo: - Age: - |
NRG2 | 2.714 | - | - | 0.957 | 0.846 | 0.911 | - | Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218} |
51. | MligTC455_11863 | 67 | 1.4 | Mlig455_037840 | Neo: - Age: - Region-enriched R7: 3.761/0.04261 |
GRM3 | 2.712 | - | - | 0.983 | 0.803 | 0.926 | - | Mlig455_037840 {REF} {Length: 3733} {Pfam: Receptor family ligand binding region [PF01094.30, score=244.3]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=189.6]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=36.4]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=701, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=626, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=818, Expect=0.0]} {RNA1310_32870} {RNA815_40865} |
52. | MligTC455_33317 | 89 | 1.85 | Mlig455_027356 | Neo: - Age: logFC(26M/2M)=0.510 |
CASK | 2.689 | - | - | - | 0.819 | 0.954 | 0.916 | Mlig455_027356 {REF} {Length: 7545} {Pfam: PDZ domain [PF00595.26, score=49.9]; L27 domain [PF02828.18, score=40.8]} {Human: ENSG00000147044, CASK, calcium/calmodulin dependent serine protein kinase, [Score=208, Expect=3e-59]} {Mouse: ENSMUSG00000031012, Cask, calcium/calmodulin-dependent serine protein kinase (MAGUK family), [Score=207, Expect=9e-57]} {Dmel: FBgn0013759, CASK, [Score=193, Expect=7e-52]} {Celegans: WBGene00002991, lin-2, [Score=124, Expect=1e-29]} {Smed: dd_Smed_v6_7723_0_4, dd_Smed_v6_7723_0_4, [Score=217, Expect=1e-60]} {RNA1509_30764} {RNA1310_4720.1} {RNA815_18816} |
53. | MligTC455_14830 | 177 | 3.68 | Mlig455_066372 | Neo: - Age: - |
SSUH2 | 2.67 | - | - | 0.801 | - | 0.897 | 0.972 | Mlig455_066372 {REF} {Length: 1569} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=2e-53]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=1e-40]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=119, Expect=2e-29]} {RNA1509_46058} {RNA1310_5028.1, RNA1509_46058} {RNA1509_46058, RNA815_5650} |
54. | MligTC455_14085 | 29 | 0.61 | Mlig455_002893 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.406/0.01193 |
PPP2R5D | 2.669 | - | - | 0.801 | - | 0.979 | 0.889 | Mlig455_002893 {REF} {Length: 4141} {Pfam: Protein phosphatase 2A regulatory B subunit (B56 family) [PF01603.22, score=580.3]} {Human: ENSG00000112640, PPP2R5D, protein phosphatase 2 regulatory subunit B'delta, [RH, Score=675, Expect=0.0]; ENSG00000078304, PPP2R5C, protein phosphatase 2 regulatory subunit B'gamma, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000059409, Ppp2r5d, protein phosphatase 2, regulatory subunit B', delta, [RH, Score=677, Expect=0.0]; ENSMUSG00000017843, Ppp2r5c, protein phosphatase 2, regulatory subunit B', gamma, [RH, Score=645, Expect=0.0]} {Dmel: FBgn0042693, wrd, well-rounded, [RH, Score=654, Expect=0.0]} {Celegans: WBGene00007554, pptr-2, Protein Phosphatase 2A (Two A) Regulatory subunit, [RH, Score=638, Expect=0.0]} {Smed: dd_Smed_v6_3379_0_1, dd_Smed_v6_3379_0_1, [RH, Score=665, Expect=0.0]} {RNA1509_7339} {RNA1310_39381} {RNA815_26062} |
55. | MligTC455_40779 | 191 | 3.98 | Mlig455_000277, Mlig455_035731, Mlig455_058356 | Neo: - Age: - Region-enriched R4: 3.665/0.04268 |
2.664 | - | - | 0.847 | 0.867 | 0.950 | - | Mlig455_000277 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_035731 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_058356 {REF} {Length: 1050} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} |
|
56. | MligTC455_25245 | 34 | 0.7 | Mlig455_006162, Mlig455_029139, Mlig455_054138, Mlig455_065758, Mlig455_068467, Mlig455_071050 | Neo: - Age: - |
2.663 | - | - | 0.872 | - | 0.952 | 0.839 | Mlig455_006162 {REF} {Length: 1019} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=23.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.5]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=60.8, Expect=6e-10]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_029139 {REF} {Length: 1958} {Pfam: Domain of unknown function (DUF4834) [PF16118.7, score=25.2]; Repeat of unknown function (DUF1502) [PF07397.13, score=19.7]; Subunit CCDC53 of WASH complex [PF10152.11, score=19.2]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=82.4, Expect=3e-16]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_054138 {REF} {Length: 1019} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=22.9]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=80.1, Expect=3e-16]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_065758 {REF} {Length: 977} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=73.9, Expect=3e-14]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_068467 {REF} {Length: 1103} {Pfam: Repeat of unknown function (DUF1502) [PF07397.13, score=29.2]} {Dmel: FBgn0032638, SPH93, Serine protease homolog 93, [Score=86.7, Expect=2e-18]} {RNA1509_21624} {RNA1310_7883} {RNA815_57704} Mlig455_071050 {REF} {Length: 668} {TRANSSPLICED} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=32.5]} {RNA1509_21624} {RNA1310_7883} {RNA815_36144} |
|
57. | MligTC455_45665 | 1443 | 30.07 | Mlig455_011779 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.663 Region-enriched R2: 1.647/0.04427 Regeneration-depleted R6: -3.147 |
2.661 | - | - | - | 0.830 | 0.881 | 0.950 | Mlig455_011779 {REF} {Length: 735} {TRANSSPLICED} {RNA1509_33726} {RNA1310_46610, RNA1509_33726} {RNA1509_33726, RNA815_23273} | |
58. | MligTC455_50053 | 284 | 5.92 | Mlig455_030746 | Neo: - Age: - Region-enriched R2: 1.768/0.02980 |
STOM | 2.656 | - | - | 0.813 | - | 0.955 | 0.888 | Mlig455_030746 {REF} {Length: 2635} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=58.5]} {Human: ENSG00000148175, STOM, stomatin, [Score=257, Expect=7e-85]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=253, Expect=2e-83]} {Dmel: FBgn0260657, CG42540, [Score=262, Expect=9e-86]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=275, Expect=6e-91]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [Score=304, Expect=4e-104]} {RNA1509_53478} {RNA1310_8094.2} {RNA815_8739} |
59. | MligTC455_35436 | 244 | 5.09 | Mlig455_066072 | Neo: - Age: - Region-enriched R2: 2.834/0.01983 |
GLRA2 | 2.655 | - | - | 0.907 | - | 0.789 | 0.959 | Mlig455_066072 {REF} {Length: 4141} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.1]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=249, Expect=7e-77]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=246, Expect=1e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=241, Expect=9e-74]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=240, Expect=2e-73]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=237, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=246, Expect=4e-76]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=257, Expect=5e-80]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=448, Expect=7e-155]} {RNA1509_35986} {RNA1310_23400, RNA1509_35986} {RNA1509_35986, RNA815_18122} |
60. | MligTC455_39495 | 30 | 0.62 | Mlig455_037087 | Neo: - Age: - |
2.654 | - | - | 0.814 | 0.865 | 0.975 | - | Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
61. | MligTC455_42130 | 49 | 1.02 | Mlig455_031418 | Neo: - Age: - |
2.654 | - | - | 0.983 | - | 0.783 | 0.888 | Mlig455_031418 {REF} {Length: 1285} {RNA1310_89057} | |
62. | MligTC455_33288 | 692 | 14.41 | Mlig455_061850 | Neo: - Age: Down-Up-Up Region-specific R2: 4.145 Region-enriched R2: 4.075/0.00000 |
2.645 | - | - | 0.829 | 0.852 | 0.964 | - | Mlig455_061850 {REF} {Length: 889} {RNA1509_48963} {RNA1310_87307} {RNA815_23468} | |
63. | MligTC455_16962 | 22 | 0.45 | Mlig455_013331 | Neo: - Age: - |
PXDN | 2.644 | - | - | 0.957 | 0.800 | - | 0.887 | Mlig455_013331 {REF} {Length: 2939} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=51.7]; Immunoglobulin domain [PF13927.8, score=47.8]; Immunoglobulin domain [PF00047.27, score=41.8]; Immunoglobulin domain [PF13895.8, score=34.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=22.3]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=53.9, Expect=4e-07]; ENSG00000174498, IGDCC3, immunoglobulin superfamily DCC subclass member 3, [Score=53.1, Expect=9e-07]; ENSG00000113805, CNTN3, contactin 3, [Score=52.0, Expect=2e-06]; ENSG00000155657, TTN, titin, [Score=51.6, Expect=3e-06]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=54.3, Expect=3e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=52.8, Expect=8e-07]; ENSMUSG00000032394, Igdcc3, immunoglobulin superfamily, DCC subclass, member 3, [Score=52.8, Expect=8e-07]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=9e-07]} {Dmel: FBgn0003984, vn, vein, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00006776, unc-40, Unc-40 protein, [Score=53.9, Expect=2e-07]} {Smed: dd_Smed_v6_15790_0_1, dd_Smed_v6_15790_0_1, [RH, Score=70.5, Expect=3e-13]} {RNA1310_57623} {RNA815_38366} |
64. | MligTC455_25922 | 42 | 0.88 | Mlig455_006651 | Neo: - Age: - |
2.637 | - | - | 0.813 | 0.839 | 0.985 | - | Mlig455_006651 {REF} {Length: 1526} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
65. | MligTC455_50861 | 422 | 8.78 | Mlig455_050457 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.760/0.00000 |
CPLX2 | 2.637 | - | - | - | 0.762 | 0.958 | 0.917 | Mlig455_050457 {REF} {Length: 2902} {Pfam: Synaphin protein [PF05835.14, score=85.3]} {Human: ENSG00000145920, CPLX2, complexin 2, [RH, Score=55.1, Expect=1e-10]} {Mouse: ENSMUSG00000025867, Cplx2, complexin 2, [RH, Score=50.8, Expect=1e-08]} {Dmel: FBgn0041605, cpx, complexin, [Score=64.3, Expect=7e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=71.2, Expect=1e-16]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=78.6, Expect=1e-19]} {RNA1509_56433} {RNA1310_16525, RNA1509_56433} {RNA1509_56433, RNA815_8066.1} |
66. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 2.636 | - | - | 0.835 | 0.837 | 0.964 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
67. | MligTC455_41644 | 1214 | 25.28 | Mlig455_036599, Mlig455_057748, Mlig455_057750 | Neo: - Age: - Region-specific R2: 4.114 Region-enriched R2: 2.969/0.00052 Regeneration-downregulated BL: -8.163 Regeneration-depleted BL: -8.163 |
2.636 | - | - | 0.818 | 0.861 | - | 0.957 | Mlig455_036599 {REF} {Length: 673} {RNA1509_43529} {RNA1310_60851, RNA1509_43529} {RNA1509_43529, RNA815_37406} Mlig455_057748 {REF} {Length: 702} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} Mlig455_057750 {REF} {Length: 401} {RNA1509_43529} {RNA1310_60851} {RNA815_37406} |
|
68. | MligTC455_10082 | 430 | 8.96 | Mlig455_000403, Mlig455_000471 | Neo: - Age: - Region-enriched R2: 2.917/0.00040 |
2.633 | - | - | 0.806 | 0.874 | 0.953 | - | Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422} Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422} |
|
69. | MligTC455_19070 | 4394 | 91.54 | Mlig455_017885 | Neo: - Age: - Region-specific R2: 2.478 Region-enriched R2: 2.025/0.00000 Regeneration-downregulated R2: -1.457 Regeneration-depleted R2: -1.457 |
2.633 | - | - | - | 0.824 | 0.962 | 0.847 | Mlig455_017885 {REF} {Length: 1457} {RNA1509_18484} {RNA1310_63073.1} {RNA815_40214.1} | |
70. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 2.627 | - | 0.738 | 0.908 | - | - | 0.981 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
71. | MligTC455_43140 | 1841 | 38.34 | Mlig455_031799, Mlig455_047599 | Neo: - Age: - Region-enriched R8: 3.365/0.00001 |
GNAS | 2.624 | - | - | 0.804 | 0.868 | 0.952 | - | Mlig455_031799 {REF} {Length: 1853} {Pfam: G-protein alpha subunit [PF00503.22, score=342.0]; ADP-ribosylation factor family [PF00025.23, score=58.4]; Gtr1/RagA G protein conserved region [PF04670.14, score=24.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=19.9]} {Human: ENSG00000087460, GNAS, GNAS complex locus, [RH, Score=514, Expect=0.0]; ENSG00000141404, GNAL, G protein subunit alpha L, [RH, Score=506, Expect=1e-179]} {Mouse: ENSMUSG00000027523, Gnas, GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus, [RH, Score=512, Expect=0.0]; ENSMUSG00000024524, Gnal, guanine nucleotide binding protein, alpha stimulating, olfactory type, [RH, Score=510, Expect=0.0]} {Dmel: FBgn0001123, Galphas, G protein alpha s subunit, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001745, gsa-1, G protein, Subunit Alpha, [RH, Score=469, Expect=2e-165]} {Smed: dd_Smed_v6_6167_0_1, dd_Smed_v6_6167_0_1, [RH, Score=540, Expect=0.0]} {RNA1509_55942} {RNA1310_13501} {RNA815_7904} Mlig455_047599 {REF} {Length: 1095} {RNA1509_25915, RNA1509_33730} {RNA1310_45973, RNA1509_25915, RNA1509_33730} {RNA1509_25915, RNA1509_33730, RNA815_22813} |
72. | MligTC455_33394 | 29 | 0.6 | Mlig455_020353, Mlig455_041292 | Neo: - Age: - |
RASGRP1, RASGRP3 | 2.616 | 0.768 | - | - | 0.867 | 0.981 | - | Mlig455_020353 {REF} {Length: 2230} {Pfam: RasGEF domain [PF00617.21, score=61.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=51.4]; EF hand [PF00036.34, score=33.2]; EF-hand domain [PF13405.8, score=32.5]; EF-hand domain pair [PF13499.8, score=28.5]; EF hand [PF13202.8, score=28.0]} {Human: ENSG00000152689, RASGRP3, RAS guanyl releasing protein 3, [Score=360, Expect=2e-115]; ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [Score=349, Expect=6e-110]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [Score=356, Expect=2e-114]} {Dmel: FBgn0003093, Pkc98E, Protein C kinase 98E, [Score=65.1, Expect=9e-11]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=302, Expect=3e-94]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [Score=270, Expect=3e-85]} {RNA1310_83329} Mlig455_041292 {REF} {Length: 3588} {Pfam: RasGEF domain [PF00617.21, score=145.2]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=52.4]; EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.3]; EF-hand domain pair [PF13499.8, score=30.9]; EF hand [PF13202.8, score=29.5]; EF-hand domain pair [PF13833.8, score=19.2]} {Human: ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [RH, Score=451, Expect=8e-148]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [RH, Score=453, Expect=2e-150]; ENSMUSG00000027347, Rasgrp1, RAS guanyl releasing protein 1, [RH, Score=438, Expect=3e-143]} {Dmel: FBgn0034158, CG5522, [Score=95.9, Expect=3e-20]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=416, Expect=2e-136]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [RH, Score=288, Expect=3e-91]} {RNA1509_53196} {RNA1310_34349} {RNA815_31634} |
73. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.612 | - | - | - | 0.873 | 0.950 | 0.789 | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
74. | MligTC455_21974 | 1557 | 32.43 | Mlig455_021416 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.546 Region-specific R2: 3.190 Region-enriched R2: 2.971/0.00000 |
BMPER | 2.6 | - | - | 0.858 | 0.784 | 0.958 | - | Mlig455_021416 {REF} {Length: 22453} {Pfam: Domain of unknown function (DUF1943) [PF09172.13, score=157.5]; von Willebrand factor type D domain [PF00094.27, score=57.2]; Domain of Unknown Function (DUF1081) [PF06448.13, score=32.7]; C8 domain [PF08742.13, score=24.8]; Neurensin [PF14927.8, score=24.5]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=79.0, Expect=2e-13]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=79.0, Expect=3e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=76.6, Expect=2e-12]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=77.0, Expect=6e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=7e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=241, Expect=9e-63]} {RNA1509_31} {RNA1310_7.1} {RNA815_4} |
75. | MligTC455_48518 | 1365 | 28.44 | Mlig455_004430, Mlig455_004445 | Neo: - Age: - Region-enriched R6: 4.827/0.00024 |
2.591 | - | - | 0.769 | 0.861 | 0.961 | - | Mlig455_004430 {REF} {Length: 3275} {Pfam: GDNF/GAS1 domain [PF02351.18, score=23.6]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=113, Expect=2e-25]} {RNA1509_50708} {RNA1310_13399, RNA1509_50708} {RNA1509_50708, RNA815_36630} Mlig455_004445 {REF} {Length: 796} {RNA1509_12695} {RNA1310_66704} {RNA815_33428} |
|
76. | MligTC455_20015 | 52 | 1.09 | Mlig455_026589 | Neo: - Age: - |
2.588 | - | - | 0.786 | 0.840 | - | 0.962 | Mlig455_026589 {REF} {Length: 611} {RNA1310_66647} {RNA815_33955} | |
77. | MligTC455_48517 | 682 | 14.21 | Mlig455_004431 | Neo: - Age: - Region-enriched R6: 4.694/0.00066 |
2.588 | - | - | 0.767 | 0.861 | 0.960 | - | Mlig455_004431 {REF} {Length: 3101} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=112, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_33428} | |
78. | MligTC455_13376 | 101 | 2.1 | Mlig455_040613 | Neo: - Age: - Region-specific R2: 4.973 Region-enriched R2: 6.158/0.00016 |
2.587 | 0.753 | 0.881 | - | - | - | 0.953 | Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961} | |
79. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
2.587 | - | - | - | 0.757 | 0.950 | 0.880 | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
80. | MligTC455_33848 | 177 | 3.7 | Mlig455_000010, Mlig455_000046 | Neo: - Age: logFC(26M/2M)=-0.353 |
GRIA2 | 2.587 | 0.854 | - | - | 0.753 | 0.980 | - | Mlig455_000010 {REF} {Length: 3793} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.7]; Receptor family ligand binding region [PF01094.30, score=103.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=41.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=22.2]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=462, Expect=2e-146]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=456, Expect=1e-143]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=453, Expect=9e-143]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=449, Expect=2e-141]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=459, Expect=1e-145]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=457, Expect=2e-144]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=457, Expect=2e-144]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=449, Expect=1e-141]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [Score=399, Expect=1e-121]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=328, Expect=3e-96]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [Score=522, Expect=4e-169]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} Mlig455_000046 {REF} {Length: 3946} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.4]; Receptor family ligand binding region [PF01094.30, score=125.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=83.5]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=561, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=550, Expect=2e-179]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [RH, Score=545, Expect=2e-177]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=557, Expect=0.0]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [RH, Score=545, Expect=9e-178]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=521, Expect=2e-167]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [RH, Score=390, Expect=4e-119]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [RH, Score=681, Expect=0.0]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} |
81. | MligTC455_21975 | 1445 | 30.1 | Mlig455_067235 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.598 Region-specific R2: 3.235 Region-enriched R2: 3.090/0.00000 |
BMPER | 2.586 | - | - | 0.850 | 0.776 | 0.960 | - | Mlig455_067235 {REF} {Length: 21751} {Pfam: von Willebrand factor type D domain [PF00094.27, score=57.1]; C8 domain [PF08742.13, score=24.9]; Neurensin [PF14927.8, score=24.8]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=80.9, Expect=4e-14]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=78.6, Expect=4e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=78.6, Expect=5e-13]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=78.6, Expect=2e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=6e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=244, Expect=8e-64]} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_31, RNA1509_5282} {RNA1310_7.1, RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282, RNA815_4} |
82. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 2.582 | - | - | 0.891 | 0.725 | 0.966 | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
83. | MligTC455_50659 | 51 | 1.05 | Mlig455_019368 | Neo: - Age: Up-Down-Down |
SLC9B2 | 2.572 | 0.743 | - | 0.971 | - | - | 0.858 | Mlig455_019368 {REF} {Length: 4402} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=107.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=318, Expect=5e-99]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=307, Expect=1e-94]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=274, Expect=1e-80]} {Celegans: WBGene00009617, F41E7.1, [RH, Score=131, Expect=6e-32]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=348, Expect=1e-111]} {RNA1509_53260} {RNA1310_33802} {RNA815_25816} |
84. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.552 | 0.750 | - | - | - | 0.851 | 0.951 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
85. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 2.551 | - | - | - | 0.957 | 0.823 | 0.771 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
86. | MligTC455_41378 | 178 | 3.71 | Mlig455_030228, Mlig455_068007 | Neo: - Age: Down-Up-Down |
TET2 | 2.53 | 0.728 | - | 0.852 | 0.950 | - | - | Mlig455_030228 {REF} {Length: 3771} {Pfam: Oxygenase domain of the 2OGFeDO superfamily [PF12851.9, score=168.3]} {Human: ENSG00000168769, TET2, tet methylcytosine dioxygenase 2, [RH, Score=281, Expect=1e-79]} {Mouse: ENSMUSG00000034832, Tet3, tet methylcytosine dioxygenase 3, [Score=278, Expect=1e-78]; ENSMUSG00000040943, Tet2, tet methylcytosine dioxygenase 2, [Score=269, Expect=1e-75]} {Dmel: FBgn0263392, Tet, Ten-Eleven Translocation (TET) family protein, [Score=284, Expect=6e-81]} {RNA1310_10331} {RNA815_41425} Mlig455_068007 {REF} {Length: 3865} {Pfam: Oxygenase domain of the 2OGFeDO superfamily [PF12851.9, score=170.1]} {Human: ENSG00000168769, TET2, tet methylcytosine dioxygenase 2, [RH, Score=285, Expect=3e-80]} {Mouse: ENSMUSG00000034832, Tet3, tet methylcytosine dioxygenase 3, [Score=281, Expect=3e-79]; ENSMUSG00000040943, Tet2, tet methylcytosine dioxygenase 2, [Score=273, Expect=2e-76]} {Dmel: FBgn0263392, Tet, Ten-Eleven Translocation (TET) family protein, [RH, Score=287, Expect=2e-81]} {RNA1310_10331} {RNA815_43742} |
87. | MligTC455_48655 | 235 | 4.9 | Mlig455_016685, Mlig455_051240 | Neo: - Age: - |
ONECUT1 | 2.527 | 0.744 | - | 0.966 | 0.817 | - | - | Mlig455_016685 {REF} {Length: 3882} {Pfam: CUT domain [PF02376.17, score=113.6]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=214, Expect=1e-62]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=186, Expect=4e-52]; ENSMUSG00000045991, Onecut2, one cut domain, family member 2, [Score=185, Expect=7e-52]; ENSMUSG00000045518, Onecut3, one cut domain, family member 3, [Score=184, Expect=3e-51]} {Dmel: FBgn0028996, onecut, [Score=217, Expect=1e-60]} {Celegans: WBGene00015934, ceh-48, One cut domain family member, [Score=187, Expect=6e-53]} {Smed: dd_Smed_v6_16472_0_1, dd_Smed_v6_16472_0_1, [Score=214, Expect=2e-60]} {RNA1509_56542} {RNA1310_35187} {RNA815_16352} Mlig455_051240 {REF} {Length: 3794} {Pfam: CUT domain [PF02376.17, score=113.5]; Homeodomain [PF00046.31, score=43.2]; Homeobox KN domain [PF05920.13, score=22.7]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=276, Expect=8e-86]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=276, Expect=8e-86]} {Dmel: FBgn0028996, onecut, [Score=283, Expect=2e-83]} {Celegans: WBGene00000459, ceh-38, Homeobox protein ceh-38, [Score=201, Expect=1e-56]} {Smed: dd_Smed_v6_25197_0_2, dd_Smed_v6_25197_0_2, [Score=259, Expect=1e-76]} {RNA1509_56542} {RNA1310_35187, RNA1509_56542} {RNA1509_56542, RNA815_16352} |
88. | MligTC455_40878 | 355 | 7.39 | Mlig455_014130 | Neo: - Age: - |
2.526 | - | - | - | 0.743 | 0.816 | 0.967 | Mlig455_014130 {REF} {Length: 1465} {RNA1509_7458} {RNA1310_36212} {RNA815_1610.1} | |
89. | MligTC455_52550 | 164 | 3.41 | Mlig455_002239 | Neo: - |
2.516 | - | - | 0.952 | 0.733 | 0.831 | - | Mlig455_002239 {REF} {Length: 3509} {Pfam: Innexin [PF00876.20, score=62.4]} {Smed: dd_Smed_v6_9861_0_1, dd_Smed_v6_9861_0_1, [Score=60.1, Expect=9e-10]} {RNA1509_36214} {RNA1310_17023} {RNA815_33132} | |
90. | MligTC455_45178 | 335 | 6.98 | Mlig455_062775 | Neo: - Age: - |
2.508 | 0.760 | - | 0.958 | - | 0.790 | - | Mlig455_062775 {REF} {Length: 2253} {RNA1310_27338.1} {RNA815_16921} | |
91. | MligTC455_46669 | 2174 | 45.3 | Mlig455_010563 | Neo: - Age: - Region-enriched R7: 2.715/0.00000 Regeneration-downregulated BL: -4.462 Regeneration-depleted BL: -4.462 |
2.491 | - | - | 0.748 | 0.775 | 0.968 | - | Mlig455_010563 {REF} {Length: 1146} {TRANSSPLICED} {Pfam: Protein of unknown function (DUF3105) [PF11303.10, score=111.6]} {Dmel: FBgn0035372, CG12093, [RH, Score=120, Expect=9e-32]} {Celegans: WBGene00012755, Y41C4A.8, [RH, Score=154, Expect=6e-46]} {RNA1509_12854, RNA1509_15128, RNA1509_35297} {RNA1310_20233, RNA1509_12854, RNA1509_15128, RNA1509_35297} {RNA1509_12854, RNA1509_15128, RNA1509_35297, RNA815_9751} | |
92. | MligTC455_50773 | 94 | 1.96 | Mlig455_066501 | Neo: - Age: logFC(26M/2M)=-0.807 |
2.479 | - | - | 0.959 | 0.711 | - | 0.809 | Mlig455_066501 {REF} {Length: 2527} {Pfam: Innexin [PF00876.20, score=406.7]} {Dmel: FBgn0085387, shakB, shaking B, [Score=123, Expect=6e-31]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=333, Expect=1e-110]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=506, Expect=1e-177]} {RNA1509_51082} {RNA1310_30234.1} {RNA815_8755} | |
93. | MligTC455_53489 | 93 | 1.93 | Mlig455_055317 | Neo: - Age: Down-Up-Down |
FBXL7 | 2.475 | 0.705 | - | 0.801 | - | - | 0.969 | Mlig455_055317 {REF} {Length: 3638} {Pfam: Leucine Rich repeat [PF13516.8, score=53.5]; F-box-like [PF12937.9, score=45.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=31.8]; F-box domain [PF00646.35, score=28.5]} {Human: ENSG00000183580, FBXL7, F-box and leucine rich repeat protein 7, [RH, Score=176, Expect=2e-47]} {Mouse: ENSMUSG00000043556, Fbxl7, F-box and leucine-rich repeat protein 7, [RH, Score=177, Expect=4e-48]} {Dmel: FBgn0038385, Fbxl7, F-box and leucine-rich repeat protein 7, [RH, Score=176, Expect=2e-46]} {Celegans: WBGene00015350, fbxl-1, Uncharacterized F-box/LRR-repeat protein C02F5.7, [Score=112, Expect=3e-26]} {Smed: dd_Smed_v6_10647_0_1, dd_Smed_v6_10647_0_1, [RH, Score=114, Expect=2e-26]} {RNA1310_5789.1} {RNA815_11910} |
94. | MligTC455_17565 | 85 | 1.77 | Mlig455_054318 | Neo: - Age: - Region-enriched R2: 6.111/0.00708 |
2.467 | - | - | 0.708 | 0.798 | 0.961 | - | Mlig455_054318 {REF} {Length: 550} {RNA1310_73705} {RNA815_38857} | |
95. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
2.462 | 0.734 | 0.778 | - | - | - | 0.950 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
96. | MligTC455_37683 | 97 | 2.03 | Mlig455_027754 | Neo: - Age: - |
KCNN2 | 2.457 | - | 0.719 | - | 0.964 | 0.774 | - | Mlig455_027754 {REF} {Length: 1617} {Pfam: Calmodulin binding domain [PF02888.18, score=117.1]; Ion channel [PF07885.18, score=49.9]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=359, Expect=1e-120]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=353, Expect=1e-120]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=343, Expect=4e-115]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=358, Expect=1e-120]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=353, Expect=2e-116]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=400, Expect=1e-137]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=303, Expect=2e-98]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [Score=355, Expect=1e-118]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_9828.1} |
97. | MligTC455_53466 | 67 | 1.39 | Mlig455_070695 | Neo: - Age: Up-Down-Down |
2.45 | - | - | 0.730 | 0.965 | 0.755 | - | Mlig455_070695 {REF} {Length: 2622} {Pfam: PDZ domain [PF00595.26, score=27.1]} {RNA1310_42258} {RNA815_27727} | |
98. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
2.414 | 0.707 | 0.757 | - | - | 0.950 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
99. | MligTC455_29049 | 441 | 9.18 | Mlig455_042244 | Neo: - Age: - Region-enriched R2: 4.677/0.00000 |
RASGRF1 | 1.92 | - | - | 0.943 | - | - | 0.977 | Mlig455_042244 {REF} {Length: 6465} {Pfam: RasGEF domain [PF00617.21, score=193.2]; RhoGEF domain [PF00621.22, score=119.3]; PH domain [PF00169.31, score=86.7]; RasGEF N-terminal motif [PF00618.22, score=68.4]; Pleckstrin homology domain [PF15413.8, score=22.6]} {Human: ENSG00000058335, RASGRF1, Ras protein specific guanine nucleotide releasing factor 1, [RH, Score=763, Expect=0.0]; ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [RH, Score=739, Expect=0.0]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [RH, Score=763, Expect=0.0]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=164, Expect=3e-40]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=118, Expect=3e-26]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [RH, Score=1137, Expect=0.0]} {RNA1509_15697} {RNA1310_2543.1} {RNA815_8228.1} |
100. | MligTC455_34749 | 10 | 0.21 | Mlig455_026129 | Neo: - Age: Up-Down-Down |
RASGRF2 | 1.919 | - | - | - | - | 0.968 | 0.951 | Mlig455_026129 {REF} {Length: 5810} {Pfam: RasGEF domain [PF00617.21, score=176.1]; RhoGEF domain [PF00621.22, score=96.8]; RasGEF N-terminal motif [PF00618.22, score=65.5]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=21.2]} {Human: ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [Score=506, Expect=3e-158]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [Score=484, Expect=2e-149]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=136, Expect=6e-32]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=105, Expect=1e-22]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [Score=747, Expect=0.0]} {RNA1509_15697} {RNA1310_18289} {RNA815_21605.1} |